Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
9.95
-0.62 (-5.87%)
At close: Nov 20, 2026, 4:00 PM EST
10.07
+0.12 (1.21%)
After-hours: Nov 20, 2026, 7:54 PM EST
Summit Therapeutics Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Summit Therapeutics stock has a consensus rating of "Buy" and an average price target of $28.77. The average 1-year stock price forecast is 189.15% higher than the current stock price, while the lowest is $8.21 (-17.46%) and the highest is $42.53 (+327.44%).
Price Target: $28.77 (+189.15%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Summit Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 10 | 10 | 10 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 7 | 6 | 6 | 5 |
| Sell | 2 | 2 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold Maintains $13 → $11 | Hold | Maintains | $13 → $11 | +10.55% | Nov 18, 2026 |
| Bernstein | Bernstein | Sell Downgrades $12 → $8.3 | Sell | Downgrades | $12 → $8.3 | -16.58% | Nov 18, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $37 | Buy | Maintains | $37 | +271.86% | Nov 16, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $43 | Buy | Maintains | $43 | +332.16% | Nov 16, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $16 | Hold | Maintains | $16 | +60.80% | Nov 16, 2026 |
Financial Forecast
Revenue This Year
1.41M
Revenue Next Year
34.53M
from 1.41M
Increased by 2,353.06%
EPS This Year
-1.03
from -1.39
EPS Next Year
-1.04
from -1.03
EPS and Forward PE are based on non-GAAP adjusted numbers.